首页> 外文OA文献 >Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin and Paclitaxel in Unresectable Stage IIIA/B Non-small Cell Lung Cancer

【2h】

Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin and Paclitaxel in Unresectable Stage IIIA/B Non-small Cell Lung Cancer

机译：不可切除的IIIA / B期非小细胞肺癌的I / II期临床试验的剂量递增的三维共形胸部放疗联合诱导和同时卡铂和紫杉醇的长期随访。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Stinchcombe Thomas E.; Lee Carrie B.; Moore Dominic T.; Rivera M Patricia; Halle Jan; Limentani Steven; Rosenman Julian G.; Socinski Mark A.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 不能手术的Ⅲ期非小细胞肺癌患者每周紫杉醇和卡铂并同步放疗的诱导化疗：一个Ⅱ期研究结果 [J] . Hend Ahmed El-Hadaad, Hanan Ahmed Wahba, Eman Toson 中德临床肿瘤学杂志（英文版） . 2013,第002期
2. Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer [J] . StinchcombeT.E., LeeC.B., MooreD.T., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第11期

机译：I / II期临床试验的长期随访，涉及剂量递增的三维共形胸廓放疗联合诱导性卡铂和紫杉醇治疗不可切除的IIIA / B期非小细胞肺癌
3. Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer. [J] . Stinchcombe TE, Morris DE, Lee CB, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第3期

机译：不可切除的IIIA期和IIIB期非小细胞肺癌患者先用卡铂，伊立替康和紫杉醇诱导化疗，然后进行高剂量三维保形胸放疗（74 Gy）并用卡铂，紫杉醇和吉非替尼。
4. Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non-Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial. [J] . Socinski MA, Morris DE, Halle JS, Journal of Clinical Oncology . 2004,第21期

机译：不可切除的IIIA期和IIIB期非小细胞肺癌的大剂量胸廓适形放射治疗的诱导和同步化疗：剂量递增I期试验。
5. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
6. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
7. Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer [O] . Gerold Bepler, Thomas J. Dilling, Henry Wagner, -1

机译：诱导吉西他滨和卡铂的II期试验然后用每周紫杉醇和卡铂在不可切除的阶段III非小细胞肺癌中保全胸腔辐射至74吨。
8. Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer [O] . Stinchcombe Thomas E., Morris David E., Lee Carrie B., 2008

机译：不可切除的IIIA期和IIIB期非小细胞肺癌患者先后用卡铂，伊立替康和紫杉醇进行诱导化学疗法，然后进行大剂量三维共形胸廓放疗（74 Gy），并用卡铂，紫杉醇和吉非替尼。

Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin and Paclitaxel in Unresectable Stage IIIA/B Non-small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅